help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0624
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/10/3718    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fetita, L.-S.
Right arrow Articles by Gautier, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fetita, L.-S.
Right arrow Articles by Gautier, J.-F.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 10 3718-3724
Copyright © 2006 by The Endocrine Society


REVIEW

Consequences of Fetal Exposure to Maternal Diabetes in Offspring

Lila-Sabrina Fetita, Eugène Sobngwi, Patricia Serradas, Fabien Calvo and Jean-François Gautier

Assistance Publique-Hopitaux de Paris (L.-S.F., E.S., J.-F.G.), Department of Endocrinology and Diabetes, Saint-Louis Hospital, University Paris 7, 75475 Paris Cedex 10, France; Institut National de la Santé et de la Recherche Médicale Unité 671 (E.S., J.-F.G.), Cordelier Institute of Biomedical Research, 75270 Paris Cedex 06, France; Institut National de la Santé et de la Recherche Médicale CIC9504 (L.-S.F., E.S., F.C., J.-F.G.), University Paris 7, Assistance Publique-Hopitaux de Paris, Saint-Louis Hospital, 75475 Paris Cedex 10, France; Centre National de la Recherche Scientifique Unité Mixte de Recherche 7059 (P.S.), Laboratory of Nutrition Physiopathology, University Paris 7, 75005 Paris, France; and School of Population and Health Sciences (E.S.), Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU, United Kingdom

Address all correspondence and requests for reprints to: Jean-François Gautier, Department of Endocrinology and Diabetes, Saint-Louis Hospital, 1, Avenue Claude Vellefaux, 75475 Paris Cedex 10, France. E-mail: jean-francois.gautier{at}sls.aphp.fr.

Context: Type 2 diabetes is the result of both genetic and environmental factors. Fetal exposure to maternal diabetes is associated with a higher risk of abnormal glucose homeostasis in offspring beyond that attributable to genetic factors, and therefore, may participate in the excess of maternal transmission of type 2 diabetes.

Evidence acquisition: A MEDLINE search covered the period from 1960–2005.

Evidence synthesis: Human studies performed in children and adolescents suggest that offspring who had been exposed to maternal diabetes during fetal life exhibit higher prevalence of impaired glucose tolerance and markers of insulin resistance. Recent studies that directly measured insulin sensitivity and insulin secretion have shown an insulin secretory defect even in the absence of impaired glucose tolerance in adult offspring. In animal models, exposure to a hyperglycemic intrauterine environment also led to the impairment of glucose tolerance in the adult offspring. These metabolic abnormalities were transmitted to the next generations, suggesting that in utero exposure to maternal diabetes has an epigenetic impact. At the cellular level, some findings suggest an impaired pancreatic ß-cell mass and function. Several mechanisms such as defects in pancreatic angiogenesis and innervation, or modification of parental imprinting, may be implicated, acting either independently or in combination.

Conclusion: Thus, fetal exposure to maternal diabetes may contribute to the worldwide diabetes epidemic. Public health interventions targeting high-risk populations should focus on long-term follow-up of subjects who have been exposed in utero to a diabetic environment and on a better glycemic control during pregnancy.




This article has been cited by other articles:


Home page
DiabetesHome page
T. Nehiri, J.-P. Duong Van Huyen, M. Viltard, C. Fassot, D. Heudes, N. Freund, G. Deschenes, P. Houillier, P. Bruneval, and M. Lelievre-Pegorier
Exposure to Maternal Diabetes Induces Salt-Sensitive Hypertension and Impairs Renal Function in Adult Rat Offspring
Diabetes, August 1, 2008; 57(8): 2167 - 2175.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. A. Ingram, I. Z. Lien, L. E. Mead, M. Estes, D. N. Prater, E. Derr-Yellin, L. A. DiMeglio, and L. S. Haneline
In Vitro Hyperglycemia or a Diabetic Intrauterine Environment Reduces Neonatal Endothelial Colony-Forming Cell Numbers and Function
Diabetes, March 1, 2008; 57(3): 724 - 731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society